Healius
- Short interest
- 2.45%
- −5.69 pp 30d
- as of 9 Oct 2026
- Reported shorts
- 17.8M
- Shares on issue
- 726.179M
Healius (HLS) Short Interest
Healius (ASX:HLS) had 2.45% of shares reported as short positions as of 9 Oct 2026, representing 17,791,338 shares. Healius operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Healius
Healius is a leading Australian diagnostics company providing essential healthcare services through a vast network of labs and diagnostic centers. With a focus on accessible and affordable healthcare, Healius leverages digital technologies to enhance service delivery and patient care.
Company profile →Healius (ASX:HLS) has 2.45% of its shares on issue reported as short positions as of 9 Oct 2026, or about 17,791,338 shares. Over the past 30 days that figure has fallen 5.69 percentage points, and over 90 days it has fallen 7.84 percentage points. Its highest recorded short interest was 10.81% in June 2026. HLS is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads HLS today
- Zanger BreakoutWatchScore 8rank 1674 of 1893
- CAN SLIMWatchScore 8rank 1259 of 1549
- Minervini Trend TemplateWatchScore 8rank 1395 of 1684
- Crowded-Short BreakoutWatchScore 8rank 1229 of 1448
- Quality compoundersWatchScore 15rank 1028 of 1660
Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
HLS fundamentals
In the year to 30 Jun 2026, Healius (ASX:HLS) recorded revenue of A$1.4B and a net loss after tax of A$415.6M. A year earlier it recorded revenue of A$1.3B and a net loss after tax of A$151.2M. Year-on-year growth: revenue +2.2% (FY). Net margin −30.3% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest HLS news
All news- Is Healius (ASX:HLS) Cleaner After the Agilex Sale?
kalkine · 9 Oct 2026
- Can the Agilex Sale Reset Healius's Story (ASX:HLS)?
kalkine · 8 Oct 2026
- Becoming a substantial holder from MUFG
asx · 5 Oct 2026
Company details
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss HLS
Start a research thread or post the first pulse update